Human microbiome churns out thousands of tiny novel proteins

Because they are so small — fewer than 50 amino acids in length — it’s likely the proteins fold into unique shapes that represent previously unidentified biological building blocks. If the shapes and functions of these proteins can be recreated in the lab, they could help researchers advance scientific understanding of how the microbiome affects human health and pave the way for new drug discovery.

A paper describing the research findings was published Aug. 8 in Cell. Ami Bhatt, MD, PhD, assistant professor of medicine and of genetics, is the senior author. Postdoctoral scholar Hila Sberro, PhD, is the lead author.

‘A clear blind spot’

“It’s critically important to understand the interface between human cells and the microbiome,” Bhatt said. “How do they communicate? How do strains of bacteria protect themselves from other strains? These functions are likely to be found in very small proteins, which may be more likely than larger proteins to be secreted outside the cell.”

But the proteins’ miniscule size had made it difficult to identify and study them using traditional methods.

“We’ve been more likely to make an error than to guess correctly when trying to predict which bacterial DNA sequences contain these very small genes,” Bhatt said. “So until now, we’ve systematically ignored their existence. It’s been a clear blind spot.”

The fact that she found thousands of new protein families definitely surprised us all.

It might be intimidating for the uninitiated to think too deeply about the vast numbers of bacteria that live on and in each of us. They account for far more cells in and on the human body than actual human cells do. Yet these tiny passengers are rarely malicious. Instead, they help with our digestion, supplement our diet and generally keep us running at our peak. But in many cases, it’s been difficult to pick apart the molecular minutiae behind this partnership.

Bhatt and her colleagues wondered if answers might be found in the small proteins they knew were likely to wiggle through the nets cast by other studies focusing on the microbiome. Small proteins, they reasoned, are more likely than their larger cousins to slip through the cell membrane to ferry messages — or threats — to neighboring host or bacterial cells. But how to identify and study these tiny Houdinis?

“The bacterial genome is like a book with long strings of letters, only some of which encode the information necessary to make proteins,” Bhatt said. “Traditionally, we identify the presence of protein-coding genes within this book by searching for combinations of letters that indicate the ‘start’ and ‘stop’ signals that sandwich genes. This works well for larger proteins. But the smaller the protein, the more likely that this technique yields large numbers of false positives that muddy the results.”

A big surprise

To tackle the problem, Sberro decided to compare potential small-protein-coding genes among many different microbes and samples. Those that were identified repeatedly in several species and samples were more likely to be true positives, she thought. When she applied the analysis to large data sets, Sberro found not the hundreds of genes she and Bhatt had expected, but tens of thousands. The proteins predicted to be encoded by the genes could be sorted into more than 4,000 related groups, or families, likely to be involved in key biological processes such as intercellular communication and warfare, as well as maintenance tasks necessary to keep the bacteria healthy.

“Honestly, we didn’t know what to expect,” Bhatt said. “We didn’t have any intuition about this. The fact that she found thousands of new protein families definitely surprised us all.”

The researchers confirmed the genes encoded true proteins by showing they are transcribed into RNA and shuttled to the ribosome for translation — key steps in the protein-making pathway in all organisms. They are now working with collaborators to learn more about the proteins’ functions and to identify those that might be important to the bacteria fighting for space in our teeming intestinal carpet. Such proteins might serve as new antibiotics or drugs for human use, they believe.

“Small proteins can be synthesized rapidly and could be used by the bacteria as biological switches to toggle between functional states or to trigger specific reactions in other cells,” Bhatt said. “They are also easier to study and manipulate than larger proteins, which could facilitate drug development. We anticipate this to be a valuable new area of biology for study.”

Researchers from One Codex, the Joint Genome Institute of the Department of Energy, the Alexander Fleming Biomedical Sciences Research Center in Greece, and Lawrence Berkeley National Laboratory also contributed to the study.

The study was supported by the National Institutes of Health (grants HG000044, K08CA184420, P30CA124435, and 1Ro1AT010123201), the PhRMA Foundation, the U.S. Department of Energy and a Damon Runyon Clinical Investigator Award.

Turonzamin is a caring, compassionate community that provides articles, topics, discussion groups, resources,... and support to help care for loved ones with a maximum informations.

Living with a Diseases & Conditions, or even a common illness can impact the daily lives of patients and families. News, articles, topics, discussion groups, … can help patients and families navigate various aspects of life with a Diseases.

All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.